COHANCE LIFESCIENCES (COHANCE) | Stock Overview & Key Data
COHANCE LIFESCIENCES Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹1,123.40 on May 5, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| COHANCE LIFESCIENCES COHANCE | 331.49B Large-cap | 0.66% | -13.56% | -11.00% | -16.86% | -16.86% | -18.21% | -18.21% | -18.21% |
| Sun Pharmaceutical SUNPHARMA | 3.98T Large-cap | 1.36% | 4.20% | -0.65% | 0.38% | -12.25% | -12.80% | 69.88% | 240.62% |
| Divi's Laboratories DIVISLAB | 1.68T Large-cap | 4.53% | 2.16% | -12.19% | 13.85% | 0.97% | -0.17% | 71.63% | 90.28% |
| Torrent TORNTPHARM | 1.21T Large-cap | -0.47% | -2.55% | 5.87% | 13.55% | 3.86% | 1.53% | 122.59% | 29.38% |
| Cipla CIPLA | 1.21T Large-cap | -0.30% | -2.48% | 1.43% | 6.89% | 2.28% | 5.11% | 36.45% | 93.40% |
| Dr. Reddy's DRREDDY | 1.03T Large-cap | 0.11% | -3.50% | -1.84% | 13.90% | -8.98% | -5.59% | 44.53% | 22.63% |
Ownership & Short Interest
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is COHANCE's 52-week high and low?
- In the last 52 weeks, COHANCE LIFESCIENCES reached a high of ₹1,123.40 (on May 8, 2025) and a low of ₹856.00 (on October 8, 2025).
- What is the market cap and P/E ratio for COHANCE?
- Curious about COHANCE LIFESCIENCES's size and valuation? Its market capitalization stands at 331.49B. When it comes to valuation, the P/E ratio (trailing twelve months) is 89.48, and the forward P/E (looking ahead) is 40.42.
- Does COHANCE pay dividends? If so, what's the yield?
- As for dividends, COHANCE LIFESCIENCES isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are COHANCE LIFESCIENCES's main competitors or similar companies to consider before investing?
When looking at COHANCE LIFESCIENCES, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.98T Healthcare Drug Manufacturers - Specialty & Generic -12.80% 69.88% Divi's Laboratories
DIVISLAB1.68T Healthcare Drug Manufacturers - Specialty & Generic -0.17% 71.63% Torrent
TORNTPHARM1.21T Healthcare Drug Manufacturers - Specialty & Generic 1.53% 122.59% Cipla
CIPLA1.21T Healthcare Drug Manufacturers - Specialty & Generic 5.11% 36.45% Dr. Reddy's
DRREDDY1.03T Healthcare Drug Manufacturers - Specialty & Generic -5.59% 44.53% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for COHANCE LIFESCIENCES LTD? (e.g., ROE, Debt/Equity)
- To get a sense of COHANCE LIFESCIENCES's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 14.55%, the Debt to Equity ratio from the most recent quarter is 15.16, and its Gross Profit Margin stands at 73.03%.
- What is the recent revenue and earnings growth for COHANCE?
- Looking at COHANCE LIFESCIENCES's growth, its revenue over the trailing twelve months (TTM) was INR13B. Compared to the same quarter last year (YoY), quarterly revenue grew by 138.10%, and quarterly earnings saw a YoY growth of -19.60%.
- How much of COHANCE stock is held by insiders and institutions?
- Wondering who owns COHANCE LIFESCIENCES stock? Company insiders (like executives and directors) hold about 64.19% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 14.98%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.